BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18266559)

  • 1. Prediction of epitopes in hemagglutinin and neuraminidase proteins of influenza A virus H5N1 strain: a clue for diagnostic and vaccine development.
    Somvanshi P; Singh V; Seth PK
    OMICS; 2008 Mar; 12(1):61-9. PubMed ID: 18266559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell epitopes in the intrinsically disordered regions of neuraminidase and hemagglutinin proteins of H5N1 and H9N2 avian influenza viruses for peptide-based vaccine development.
    Ramamurthy M; Sankar S; Abraham AM; Nandagopal B; Sridharan G
    J Cell Biochem; 2019 Oct; 120(10):17534-17544. PubMed ID: 31111560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential.
    Parida R; Shaila MS; Mukherjee S; Chandra NR; Nayak R
    Vaccine; 2007 Oct; 25(43):7530-9. PubMed ID: 17900763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lineage-specific epitope profiles for HPAI H5 pre-pandemic vaccine selection and evaluation.
    Qiu X; Duvvuri VR; Gubbay JB; Webby RJ; Kayali G; Bahl J
    Influenza Other Respir Viruses; 2017 Sep; 11(5):445-456. PubMed ID: 28715148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.
    Moise L; Terry F; Ardito M; Tassone R; Latimer H; Boyle C; Martin WD; De Groot AS
    Hum Vaccin Immunother; 2013 Jul; 9(7):1598-607. PubMed ID: 23846304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
    Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.
    Velkov T; Ong C; Baker MA; Kim H; Li J; Nation RL; Huang JX; Cooper MA; Rockman S
    Mol Immunol; 2013 Dec; 56(4):705-19. PubMed ID: 23933511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.
    Wang M; Lamberth K; Harndahl M; Røder G; Stryhn A; Larsen MV; Nielsen M; Lundegaard C; Tang ST; Dziegiel MH; Rosenkvist J; Pedersen AE; Buus S; Claesson MH; Lund O
    Vaccine; 2007 Apr; 25(15):2823-31. PubMed ID: 17254671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying conserved DR1501-restricted CD4(+) T-cell epitopes in avian H5N1 hemagglutinin proteins.
    Wang SF; Yao L; Liu SJ; Chong P; Liu WT; Chen YM; Huang JC
    Viral Immunol; 2010 Dec; 23(6):585-93. PubMed ID: 21142444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the hemagglutinin and neuraminidase genes of influenza A virus H3N2, H9N2, and H5N1 subtypes using bioinformatics techniques.
    Ahn I; Son HS
    Can J Microbiol; 2007 Jul; 53(7):830-9. PubMed ID: 17898838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitopes in the HA and NA of H5 and H7 avian influenza viruses that are important for antigenic drift.
    Luczo JM; Spackman E
    FEMS Microbiol Rev; 2024 May; 48(3):. PubMed ID: 38734891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immunogenic consensus T-cell epitopes in globally distributed influenza-A H1N1 neuraminidase.
    Gupta SK; Srivastava M; Akhoon BA; Smita S; Schmitz U; Wolkenhauer O; Vera J; Gupta SK
    Infect Genet Evol; 2011 Mar; 11(2):308-19. PubMed ID: 21094280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future needs in diagnostics and vaccines for high pathogenicity avian influenza.
    Swayne DE; Spackman E
    Dev Biol (Basel); 2013; 135():79-94. PubMed ID: 23689886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4(+) T-cell responses to internal proteins, hemagglutinins, and neuraminidases.
    Babon JA; Cruz J; Orphin L; Pazoles P; Co MD; Ennis FA; Terajima M
    Hum Immunol; 2009 Sep; 70(9):711-21. PubMed ID: 19524006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
    Ohkura T; Kikuchi Y; Kono N; Itamura S; Komase K; Momose F; Morikawa Y
    Biochem Biophys Res Commun; 2012 Feb; 418(1):38-43. PubMed ID: 22226969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.
    Khurana S; Suguitan AL; Rivera Y; Simmons CP; Lanzavecchia A; Sallusto F; Manischewitz J; King LR; Subbarao K; Golding H
    PLoS Med; 2009 Apr; 6(4):e1000049. PubMed ID: 19381279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.